Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study

Intensive Care Medicine

Volumn 38, Issue 6, 2012, Pages 950-958

  Schmittinger, Christian A ^a,b   Torgersen, Christian ^a,c   Luckner, Günter ^c   Schröder, Daniel C H ^c   Lorenz, Ingo ^c   Dünser, Martin W ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Adverse cardiac event; Catecholamines; Myocardial ischemia; Prolonged elevated heart rate; Tachyarrhythmia; Vasopressor

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; HYDROCORTISONE; HYPERTENSIVE AGENT; MILRINONE; NORADRENALIN; PHENYLEPHRINE;

ACUTE CARDIAC ARREST; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYOCARDIAL CELL DAMAGE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RENAL REPLACEMENT THERAPY; RIGHT HEART DYSFUNCTION; RISK FACTOR; SEPTIC SHOCK; SIDE EFFECT; SURGICAL WARD; SYSTEMIC CIRCULATION; TACHYCARDIA; TREATMENT DURATION;

AGED; CATECHOLAMINES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; TACHYCARDIA; VASOCONSTRICTOR AGENTS;

EID: 84862753944     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2531-2     Document Type: Article

References (39)

1. VD Mayr MW Dünser V Greil S Jochberger G Luckner H Ulmer BE Friesenecker J Takala WR Hasibeder 2006 Causes of death and determinants of outcome in critically ill patients Crit Care 10 R154 17083735 10.1186/cc5086
2. RP Dellinger MM Levy JM Carlet, et al. 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock Crit Care Med 36 296 327 18158437 10.1097/01.CCM.0000298158.12101.41
3. C Torgersen MW Dünser CA Schmittinger V Pettilä E Ruokonen V Wenzel SM Jakob J Takala 2011 Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey Eur J Anaesthesiol 28 284 290 21088597
4. A Mebazaa J Parissis R Porcher E Gayat M Nikolaou FV Boas JF Delgado F Follath 2011 Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods Intensive Care Med 37 290 301 21086112 10.1007/s00134-010-2073-4
5. MW Dünser WR Hasibeder 2009 Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress J Intensive Care Med 24 293 316 19703817 10.1177/0885066609340519
6. C Torgersen MW Dünser V Wenzel S Jochberger V Mayr CA Schmittinger I Lorenz S Schmid M Westphal W Grander G Luckner 2010 Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial Intensive Care Med 36 57 65 19756505 10.1007/s00134-009-1630-1 1:CAS:528:DC%2BC3cXotVOguw%3D%3D
7. JR Le Gall S Lemeshow F Saulnier 1993 A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 270 2957 2963 8254858 10.1001/jama.1993.03510240069035
8. JL Vincent R Moreno J Takala S Willatts A De Mendonça H Bruining CK Reinhart PM Suter LG Thijs 1996 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710 8844239 10.1007/BF01709751 1:STN:280:DyaK2s%2FgtFantQ%3D%3D
9. JA Russell KR Walley J Singer AC Gordon PC Hébert DJ Cooper CL Holmes S Mehta JT Granton MM Storms DJ Cook JJ Presneill D Ayers VASST Investigators 2008 Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 358 877 887 18305265 10.1056/NEJMoa067373 1:CAS:528:DC%2BD1cXisF2hsr4%3D
10. MW Dünser AJ Mayr H Ulmer N Ritsch H Knotzer W Pajk G Luckner NJ Mutz WR Hasibeder 2001 The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis Anesth Analg 93 7 13 11429329 10.1097/00000539-200107000-00003
11. MW Dünser AJ Mayr A Stallinger H Ulmer N Ritsch H Knotzer W Pajk NJ Mutz WR Hasibeder 2002 Cardiac performance during vasopressin infusion in postcardiotomy shock Intensive Care Med 28 746 751 12107681 10.1007/s00134-002- 1265-y
12. D Annane P Vignon A Renault PE Bollaert C Charpentier C Martin G Troché JD Ricard G Nitenberg L Papazian E Azoulay E Bellissant CATS Study Group 2007 Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial Lancet 370 676 684 17720019 10.1016/S0140-6736(07)61344-0 1:CAS:528:DC%2BD2sXpsFWrtro%3D
13. D De Backer P Biston J Devriendt C Madl D Chochrad C Aldecoa A Brasseur P Defrance P Gottignies JL Vincent SOAPII Investigators 2010 Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 779 789 20200382 10.1056/NEJMoa0907118
14. MW Dünser E Ruokonen V Pettilä H Ulmer C Torgersen CA Schmittinger S Jakob J Takala 2009 Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial Crit Care 13 R181 19917106 10.1186/cc8167
15. M Bay V Kirk J Parner C Hassager H Nielsen K Krogsgaard J Trawinski S Boesgaard J Aldershvile 2003 NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function Heart 89 150 154 12527664 10.1136/heart.89.2.150 1:CAS:528: DC%2BD3sXht1yruro%3D
16. S Talwar IB Squire PF Downie AM Mccullough MC Campton JE Davies DB Barnett LL Ng 2000 Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 1514 1521 10973765 10.1053/euhj.1999.2045 1:CAS:528: DC%2BD3cXmvVWntrw%3D
17. G Chua L Kang-Hoe 2004 Marked elevations in N-terminal brain natriuretic peptide levels in septic shock Crit Care 8 R248 R250 15312225 10.1186/cc2889
18. JL Januzzi A Morss R Tung R Pino MA Fifer BT Thompson E Lee-Lewandrowski 2006 Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study Crit Care 10 R37 16507171 10.1186/cc4839
19. B Wolff D Haase P Lazarus K Machill B Graf HG Lestin D Werner 2007 Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release Int J Cardiol 122 131 136 17258824 10.1016/j.ijcard.2006.11.051
20. Ronco C (2011) Cardio-renal syndromes: from foggy bottoms to sunny hills. Heart Fail Rev 16:509-517
21. EM Zardi A Abbate DM Zardi A Dobrina D Margiotta BW Van Tassell A Afeltra AJ Sanyal 2010 Cirrhotic cardiomyopathy J Am Coll Cardiol 56 539 549 20688208 10.1016/j.jacc.2009.12.075 1:CAS:528:DC%2BC3cXhtFKktbjM
22. E Iwai-Kanai K Hasegawa M Araki T Kakita T Morimoto S Sasayama 1999 Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes Circulation 100 305 311 10411857 1:CAS:528:DyaK1MXltVOht7s%3D
23. DL Mann RL Kent B Parsons G Cooper 4th 1992 Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 790 804 1370925 1:CAS:528:DyaK38XisV2jtLs%3D
24. T Okamoto K Adachi A Muraishi Y Seki T Hidaka H Toshima 1996 Induction of DNA breaks in cardiac myoblast cells by norepinephrine Biochem Mol Biol Int 38 821 827 8728112 1:CAS:528:DyaK2sXlvVajtg%3D%3D
25. Power I, Kam P (2001) Cardiovascular physiology. In: Power I, Kam P (eds) Principles of physiology for the anaesthetist. Arnold, London, pp 99-165
26. O Sander ID Welters P Foëx JW Sear 2005 Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications Crit Care Med 33 81 88 15644652 10.1097/01.CCM.0000150028.64264.14 discussion 241-242
27. Opie L (2004) Receptors and signal transduction. In: Opie L (ed) Heart physiology. From cell to circulation. Lippincott Williams and Wilkins, Philadelphia, pp 186-220
28. NA Flavahan JP Cooke JT Shepherd PM Vanhoutte 1987 Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs J Pharmacol Exp Ther 241 361 365 3033211 1:CAS:528:DyaL2sXktFygsLc%3D
29. A Polito E Parisini Z Ricci S Picardo D Annane 2012 Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis Intensive Care Med 38 9 19 22127480 10.1007/s00134-011-2407-x 1:CAS:528:DC%2BC3MXhs1SgtrjM
30. WO Schreuder AJ Schneider AB Groeneveld LG Thijs 1989 Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance Chest 95 1282 1288 2721267 10.1378/chest.95.6.1282 1:STN:280:DyaL1M3ltVOnsA%3D%3D
31. TA Nakada JA Russell JH Boyd R Aguirre-Hernandez KR Thain SA Thair E Nakada M McConechy KR Walley 2010 β2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock Am J Respir Crit Care Med 181 143 149 19850944 10.1164/rccm.200903-0332OC 1:CAS:528:DC%2BC3cXhvFahurg%3D
32. B Levy P Perez J Perny C Thivilier A Gerard 2011 Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study Crit Care Med 39 450 455 21037469 10.1097/CCM.0b013e3181ffe0eb 1:CAS:528:DC%2BC3MXit1eis74%3D
33. M Navarro-Sobrino J Lorita M Soley I Ramírez 2010 Catecholamine-induced heart injury in mice: differential effects of isoproterenol and phenylephrine Histol Histopathol 25 589 597 20238297 1:CAS:528:DC%2BC3cXms1Oku70%3D
34. JA Zdanowicz AC Utz I Bernasconi S Geier R Corti E Beinder 2011 "Broken heart" after cesarean delivery. Case report and review of literature Arch Gynecol Obstet 283 4 687 694 21136269 10.1007/s00404-010-1769-6
35. W Culling WJ Penny G Cunliffe NA Flores DJ Sheridan 1987 Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion J Mol Cell Cardiol 19 251 258 3037089 10.1016/S0022-2828(87)80592-8 1:CAS:528:DyaL2sXktFOmtbw%3D
36. A Mayr H Knotzer W Pajk G Luckner N Ritsch M Dünser H Ulmer W Schobersberger W Hasibeder 2001 Risk factors associated with new onset tachyarrhythmias after cardiac surgery-a retrospective analysis Acta Anaesthesiol Scand 45 543 549 11309001 10.1034/j.1399-6576.2001.045005543.x 1:STN:280:DC%2BD3M3hvV2kuw%3D%3D
37. AA Peivandi M Dahm UT Opfermann D Peetz F Doerr A Loos H Oelert 2004 Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction Herz 29 658 664 15580320 10.1007/s00059-004-2543-y
38. C Martin X Viviand S Arnaud R Vialet T Rougnon 1999 Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients Crit Care Med 27 1708 1713 10507587 10.1097/00003246-199909000-00002 1:STN:280:DyaK1MvjsFChsw%3D%3D
39. DF Goldspink JG Burniston GM Ellison WA Clark LB Tan 2004 Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol 89 407 416 15131072 10.1113/expphysiol.2004.027482 1:CAS:528:DC%2BD2cXmslWktL0%3D